Rite Aid Corp. (RAD)

0.65
0.02 3.10
NYSE : Retail Trade
Prev Close 0.67
Open 0.69
Day Low/High 0.63 / 0.69
52 Wk Low/High 0.60 / 2.12
Volume 15.46M
Avg Volume 15.20M
Exchange NYSE
Shares Outstanding 1.08B
Market Cap 750.75M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Enough Already About the Fed

There are much more important things going on.

The 7 Pillars of Healthcare Strength

Here are healthcare stocks of all shares and sizes with strong charts.

Rite Aid Looks Like the Right Move

Rite Aid Looks Like the Right Move

Feeling aggressive toward a single-digit stock.

Cramer: Stay With the Winning Horse

When they aren't winning, they're hard to turn around.

My Portfolio Report Card

My Portfolio Report Card

This portfolio is up 2.9% for the month,

Turn the Page

Turn the Page

A new portfolio for the new year.

A Combination to Knock out the Markets

Combining value, momentum, and safe holdings.

Rite Aid numbers boosted at JP Morgan

Cramer: Six Quick Rays of Light

We shouldn't expect lasting blows coming from oil's decline.

The Fibocall: Rite Aid

The Fibocall: Rite Aid

Watch today's close for the right time to buy.

Cramer: Apple Is a Win for Walgreen

Adopting Apple's payment system is a smart move.

Jim Cramer: Rite Aid and CVS Won't Play Ball With Apple Pay

Jim Cramer: Rite Aid and CVS Won't Play Ball With Apple Pay

TheStreet's Jim Cramer shares his thoughts on drug retailers Rite Aid and CVS refusing to accept Apple Pay at their stores.

Five Things to Know Now: Stress Tests and Apple

Stress test results in Europe did not reveal major shortfalls.

Moving Into the Danger Zone, Part I

Moving Into the Danger Zone, Part I

It's time to check the trends in earnings estimates.

Cramer: Walgreen Is Going Higher Long Term, Now Is an Opportunity

Cramer: Walgreen Is Going Higher Long Term, Now Is an Opportunity

With Walgreen's earnings report coming up next week, Jim Cramer says this is a stock that's been beaten up but has long-term potential.

The Fibocall: Rite Aid

The Fibocall: Rite Aid

Let's see what the technical view has to say about this sickly stock.

Rite Aid numbers cut at JP Morgan

Can Sears and Rite Aid Come Back?

I believe only one is worth owning.

Think Globally, Buy Locally

Companies with international exposure may be in for a world of hurt.

The Tell of When to Sell

If you're worried about these moves, it's time to cash out.

Risk and Stability

Staples may be read to move up, while Apple could hit triple digits.

Cramer: When Monsanto Gets Hit on Earnings, It Will Be Time to Buy

Cramer: When Monsanto Gets Hit on Earnings, It Will Be Time to Buy

Jim Cramer weighs in on two key earnings reports this week from Walgreen and Monsanto.

Jim Cramer: Tesla and Amazon Have the Headlines to Trade Higher

Jim Cramer: Tesla and Amazon Have the Headlines to Trade Higher

Jim Cramer says the secret to Tesla is that none of the big automotive companies really care about Tesla and the 35,000 electric cars that it may make.

Screens According to GARP, Part 3

Screens According to GARP, Part 3

Some names with underestimated earnings power.

Sometimes, the Discounts Aren't Right

United Tech shows why not every decline is a selling opportunity.

Away From the ECB

There's more data to be processed and interpreted. With all the attention toward the ECB, a lot of data has come out and has not been interpreted this morning. As an example, retail same-store sales numbers showed beats at L Brands (LB), Fred's (FRE...

What Makes a Bull Market?

You're looking at one.

Penney's Turn Is for Real

There will be setbacks, but it's coming back.

Fitz Bits: Boring but Rewarding

Fitz Bits: Boring but Rewarding

Let's look at few retailers and drug stores that are working.

Time for the Fed to Sell

The high-quality bond shortage is that acute.